ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Poster to Highlight ENVASARC Pivotal Trial of Envafolimab (KN035) will be presented at the 2021 ASCO Annual Meeting
May 24, 2021Alphamab Oncology announced the study design of the ENVASARC pivotal trial in the U.S. of Envafolimab (KN035), a recombinant humanized PD-L1 single domain antibody independently invented by Alphamab Oncology, will be presented by Alphamab's partner ...
Pharma Sources Insight January 2025
